124 related articles for article (PubMed ID: 3571747)
1. Beneficial long-term effect of intracoronary perfluorochemical on infarct size and ventricular function in a canine reperfusion model.
Forman MB; Puett DW; Wilson BH; Vaughn WK; Friesinger GC; Virmani R
J Am Coll Cardiol; 1987 May; 9(5):1082-90. PubMed ID: 3571747
[TBL] [Abstract][Full Text] [Related]
2. Reduction of infarct size with intracoronary perfluorochemical in a canine preparation of reperfusion.
Forman MB; Bingham S; Kopelman HA; Wehr C; Sandler MP; Kolodgie F; Vaughn WK; Friesinger GC; Virmani R
Circulation; 1985 May; 71(5):1060-8. PubMed ID: 3986976
[TBL] [Abstract][Full Text] [Related]
3. Effect of Fluosol-DA on infarct morphology and vulnerability to ventricular arrhythmia.
Kolodgie FD; Dawson AK; Roden DM; Forman MB; Virmani R
Am Heart J; 1986 Dec; 112(6):1192-201. PubMed ID: 3788766
[TBL] [Abstract][Full Text] [Related]
4. Pharmacologic perturbation of neutrophils by Fluosol results in a sustained reduction in infarct size in the canine model of reperfusion.
Forman MB; Pitarys CJ; Vildibill HD; Lambert TL; Ingram DA; Virmani R; Murray JJ
J Am Coll Cardiol; 1992 Jan; 19(1):205-16. PubMed ID: 1729335
[TBL] [Abstract][Full Text] [Related]
5. Effect of perfluorochemical (Fluosol-DA) on infarct morphology in dogs.
Kolodgie FD; Dawson AK; Forman MB; Virmani R
Virchows Arch B Cell Pathol Incl Mol Pathol; 1985; 50(2):119-34. PubMed ID: 2868560
[TBL] [Abstract][Full Text] [Related]
6. Limitation of myocardial reperfusion injury by intravenous perfluorochemicals. Role of neutrophil activation.
Bajaj AK; Cobb MA; Virmani R; Gay JC; Light RT; Forman MB
Circulation; 1989 Mar; 79(3):645-56. PubMed ID: 2537160
[TBL] [Abstract][Full Text] [Related]
7. Preservation of endothelial cell structure and function by intracoronary perfluorochemical in a canine preparation of reperfusion.
Forman MB; Puett DW; Bingham SE; Virmani R; Tantengco MV; Light RT; Bajaj A; Price R; Friesinger G
Circulation; 1987 Aug; 76(2):469-79. PubMed ID: 3608128
[TBL] [Abstract][Full Text] [Related]
8. Hyperoxic reperfusion is required to reduce infarct size after intravenous therapy with perfluorochemical (Fluosol-DA 20%) or its detergent component (poloxamer 188) in a poorly collateralized animal model. Absence of a role of polymorphonuclear leukocytes.
Kolodgie FD; Farb A; Carlson GC; Wilson PS; Virmani R
J Am Coll Cardiol; 1994 Oct; 24(4):1098-108. PubMed ID: 7930204
[TBL] [Abstract][Full Text] [Related]
9. Limitation of no reflow injury by blood-free reperfusion with oxygenated perfluorochemical (Fluosol-DA 20%).
Kolodgie FD; Virmani R; Farb A
J Am Coll Cardiol; 1991 Jul; 18(1):215-23. PubMed ID: 2050924
[TBL] [Abstract][Full Text] [Related]
10. Demonstration of myocardial reperfusion injury in humans: results of a pilot study utilizing acute coronary angioplasty with perfluorochemical in anterior myocardial infarction.
Forman MB; Perry JM; Wilson BH; Verani MS; Kaplan PR; Shawl FA; Friesinger GC
J Am Coll Cardiol; 1991 Oct; 18(4):911-8. PubMed ID: 1894864
[TBL] [Abstract][Full Text] [Related]
11. Reduction in reperfusion injury by blood-free reperfusion after experimental myocardial infarction.
Schaer GL; Karas SP; Santoian EC; Gold C; Visner MS; Virmani R
J Am Coll Cardiol; 1990 May; 15(6):1385-93. PubMed ID: 2329241
[TBL] [Abstract][Full Text] [Related]
12. The effect of perfluorochemical fluosol-DA (20%) on myocardial infarct healing in the rabbit.
Virmani R; Osmialowski AF; Kolodgie FD; Forman MB
Am J Cardiovasc Pathol; 1990; 3(1):69-80. PubMed ID: 2331363
[TBL] [Abstract][Full Text] [Related]
13. Role of perfluorochemical emulsions in the treatment of myocardial reperfusion injury.
Forman MB; Ingram DA; Murray JJ
Am Heart J; 1992 Nov; 124(5):1347-57. PubMed ID: 1442506
[TBL] [Abstract][Full Text] [Related]
14. Dose-dependent reduction of myocardial infarct size with the perfluorochemical Fluosol-DA.
Rice HE; Virmani R; Hart CL; Kolodgie FD; Farb A
Am Heart J; 1990 Nov; 120(5):1039-46. PubMed ID: 2239656
[TBL] [Abstract][Full Text] [Related]
15. Glutathione redox pathway and reperfusion injury. Effect of N-acetylcysteine on infarct size and ventricular function.
Forman MB; Puett DW; Cates CU; McCroskey DE; Beckman JK; Greene HL; Virmani R
Circulation; 1988 Jul; 78(1):202-13. PubMed ID: 3383404
[TBL] [Abstract][Full Text] [Related]
16. Effects of intracoronary infusion of arterial blood or Fluosol-DA 20% on regional myocardial metabolism and function during brief coronary artery occlusions.
Tokioka H; Miyazaki A; Fung P; Rajagopalan RE; Kar S; Meerbaum S; Corday E; Drury JK
Circulation; 1987 Feb; 75(2):473-81. PubMed ID: 2948736
[TBL] [Abstract][Full Text] [Related]
17. Infarct salvage with liposomal prostaglandin E1 administered by intravenous bolus immediately before reperfusion in a canine infarction-reperfusion model.
Smalling RW; Feld S; Ramanna N; Amirian J; Felli P; Vaughn WK; Swenson C; Janoff A
Circulation; 1995 Aug; 92(4):935-43. PubMed ID: 7641377
[TBL] [Abstract][Full Text] [Related]
18. Intravenous Fluosol in the treatment of acute myocardial infarction. Results of the Thrombolysis and Angioplasty in Myocardial Infarction 9 Trial. TAMI 9 Research Group.
Wall TC; Califf RM; Blankenship J; Talley JD; Tannenbaum M; Schwaiger M; Gacioch G; Cohen MD; Sanz M; Leimberger JD
Circulation; 1994 Jul; 90(1):114-20. PubMed ID: 8025985
[TBL] [Abstract][Full Text] [Related]
19. Myocardial protection by perfluorochemical infusion during transient ischemia produced by balloon coronary occlusion.
Virmani R; Kolodgie FD; Osmialowski A; Zimmerman P; Mergner W; Forman MB
Am Heart J; 1988 Aug; 116(2 Pt 1):421-31. PubMed ID: 2969667
[TBL] [Abstract][Full Text] [Related]
20. Prevention of ischemia during percutaneous transluminal coronary angioplasty by transcatheter infusion of oxygenated Fluosol DA 20%.
Cleman M; Jaffee CC; Wohlgelernter D
Circulation; 1986 Sep; 74(3):555-62. PubMed ID: 2943533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
